The Federal Circuit Bar Association (FCBA) will be offering a remote program entitled “Bio Pharma: Current Trends in Written Description and Enablement, and Employee Mobility” on September 22, 2021 from 11:00 am to 1:45 pm (ET). The program will consist of two panels: • Panel I — Current Topics in the Federal Circuit’s Law of Written Description and Enablement — John Josef Molenda of Steptoe & Johnson LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Henry Hadad of Bristol-Myers Squibb; Joshua Rosenkranz of Orrick, Herrington & Sutcliffe LLP; and John Whealan of The George Washington…
